These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 24937114)

  • 1. Eight-year follow-up of olanzapine therapy in a previous treatment-refractory schizophrenic patient: a case report.
    Sirota P; Benhatov R
    Int J Psychiatry Clin Pract; 2002; 6(4):211-4. PubMed ID: 24937114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety of quetiapine in treatment-refractory schizophrenia: A case report.
    Reznik R Benatov P Sirota I
    Int J Psychiatry Clin Pract; 2000; 4(1):77-80. PubMed ID: 24927319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of long-term risperidone treatment.
    Hotujac LJ; Sagud M
    Int J Psychiatry Clin Pract; 2002; 6(4):193-7. PubMed ID: 24937111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New chemotherapy approaches to psychoses].
    Olié JP; Baylé FJ
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacology of olanzapine. A review.
    Stephenson CM; Pilowsky LS
    Br J Psychiatry Suppl; 1999; (38):52-8. PubMed ID: 10884900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aripiprazole induced Parkinsonism: A case report].
    Pasquier de Franclieu S; Germain C; Petitjean F
    Encephale; 2009 Oct; 35(5):496-8. PubMed ID: 19853725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is olanzapine better than haloperidol in resistant schizophrenia? A double-blind study in partial responders.
    Altamura AC; Velonà I; Curreli R; Mundo E; Bravi D
    Int J Psychiatry Clin Pract; 2002; 6(2):107-11. PubMed ID: 24931937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States.
    Ascher-Svanum H; Furiak NM; Lawson AH; Klein TM; Smolen LJ; Conley RR; Culler SD
    J Med Econ; 2012; 15(3):531-47. PubMed ID: 22304338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stable patient with schizophrenia--from antipsychotic effectiveness to adherence.
    Thomas P
    Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S115-22. PubMed ID: 17336766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine oro-dispersible (Velotab TM ) - an alternative to depot?
    Johnson D; Rai S; Milne S
    Int J Psychiatry Clin Pract; 2002; 6(3):163-5. PubMed ID: 24945203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine as medication of first choice in therapy-resistant schizophrenia?
    À Campo J; Nijman H; Merckelbach H
    Acta Neuropsychiatr; 1998 Sep; 10(3):78-82. PubMed ID: 26971742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with olanzapine in the course of post-operative delirium associated with psychosis in geriatric patients: A report of three cases.
    Gazula HR
    Int J Psychiatry Clin Pract; 2001; 5(1):63-6. PubMed ID: 24937000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine induced tardive dystonia.
    Aggarwal A; Jiloha RC
    Indian J Pharmacol; 2008 Oct; 40(5):237-8. PubMed ID: 20040965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report.
    Okazaki K; Yamamuro K; Kishimoto T
    Neuropsychiatr Dis Treat; 2017; 13():2837-2840. PubMed ID: 29200857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine as an Adjunct in the Management of Refractory Psychogenic Excoriation With Comorbid Schizophrenia: A Case Report.
    Yeager V; Bogoyas M; Goubran B; Gonzalez L; Ferrer GF
    Cureus; 2020 Jun; 12(6):e8772. PubMed ID: 32742822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity, leucopenia and neutropenia associated with olanzapine therapy.
    Tchernichovsky E; Sirota P
    Int J Psychiatry Clin Pract; 2004; 8(3):173-7. PubMed ID: 24941207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine as a cause of urinary incontinence: a case report.
    Dada MU; Oluwole LO; Adegun PT; Tareo PO
    Iran J Psychiatry; 2012; 7(3):146-8. PubMed ID: 23139697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexisting Diogenes and Capgras syndromes.
    Nabi AA
    Int J Psychiatry Clin Pract; 2001; 5(1):75-6. PubMed ID: 24937003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.